Intuitive Surgical (ISRG) – Investment Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Intuitive Surgical (NASDAQ: ISRG) in the last few weeks:

• 10/31/2025 – Intuitive Surgical had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 10/27/2025 – Intuitive Surgical had its price target raised by analysts at Argus from $600.00 to $630.00.
• 10/26/2025 – Intuitive Surgical was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 10/24/2025 – Intuitive Surgical was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 10/24/2025 – Intuitive Surgical had its price target raised by analysts at Daiwa Capital Markets from $510.00 to $550.00. They now have an “outperform” rating on the stock.
• 10/23/2025 – Intuitive Surgical was given a new $600.00 price target on by analysts at UBS Group AG. They now have a “neutral” rating on the stock.
• 10/23/2025 – Intuitive Surgical was upgraded by analysts at Hsbc Global Res to a “strong-buy” rating.
• 10/23/2025 – Intuitive Surgical had its price target raised by analysts at HSBC Holdings plc from $595.00 to $644.00. They now have a “buy” rating on the stock.
• 10/23/2025 – Intuitive Surgical had its price target raised by analysts at Rothschild & Co Redburn from $610.00 to $615.00. They now have a “buy” rating on the stock.
• 10/22/2025 – Intuitive Surgical was given a new $575.00 price target on by analysts at Mizuho.
• 10/22/2025 – Intuitive Surgical was given a new $620.00 price target on by analysts at Truist Financial Corporation. They now have a “buy” rating on the stock.
• 10/22/2025 – Intuitive Surgical was given a new $625.00 price target on by analysts at Royal Bank Of Canada. They now have an “outperform” rating on the stock.
• 10/22/2025 – Intuitive Surgical was given a new $603.00 price target on by analysts at Raymond James Financial, Inc.. They now have an “outperform” rating on the stock.
• 10/22/2025 – Intuitive Surgical was given a new $655.00 price target on by analysts at Robert W. Baird.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at Evercore ISI from $450.00 to $540.00.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at The Goldman Sachs Group, Inc. from $567.00 to $621.00. They now have a “buy” rating on the stock.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at Jefferies Financial Group Inc. from $550.00 to $560.00. They now have a “hold” rating on the stock.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at Wells Fargo & Company from $599.00 to $600.00. They now have an “overweight” rating on the stock.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at Piper Sandler from $595.00 to $610.00. They now have an “overweight” rating on the stock.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at Leerink Partners from $593.00 to $600.00. They now have an “outperform” rating on the stock.
• 10/22/2025 – Intuitive Surgical had its price target raised by analysts at BTIG Research from $529.00 to $589.00. They now have a “buy” rating on the stock.
• 10/21/2025 – Intuitive Surgical had its “outperform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $685.00 price target on the stock.
• 10/18/2025 – Intuitive Surgical was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 10/15/2025 – Intuitive Surgical had its price target lowered by analysts at Robert W. Baird from $600.00 to $536.00. They now have an “outperform” rating on the stock.
• 10/15/2025 – Intuitive Surgical had its price target lowered by analysts at Truist Financial Corporation from $600.00 to $525.00. They now have a “buy” rating on the stock.
• 10/14/2025 – Intuitive Surgical had its price target lowered by analysts at Mizuho from $570.00 to $520.00. They now have a “neutral” rating on the stock.
• 10/13/2025 – Intuitive Surgical was given a new $529.00 price target on by analysts at UBS Group AG.
• 10/13/2025 – Intuitive Surgical had its price target lowered by analysts at BTIG Research from $571.00 to $529.00. They now have a “buy” rating on the stock.
• 10/8/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 10/7/2025 – Intuitive Surgical had its price target lowered by analysts at Evercore ISI from $535.00 to $450.00. They now have an “in-line” rating on the stock.
• 10/4/2025 – Intuitive Surgical was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 10/1/2025 – Intuitive Surgical had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $621.00 to $567.00. They now have a “buy” rating on the stock.
• 10/1/2025 – Intuitive Surgical had its “buy” rating reaffirmed by analysts at BTIG Research. They now have a $571.00 price target on the stock.
• 9/27/2025 – Intuitive Surgical had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings.
• 9/26/2025 – Intuitive Surgical was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.

Insiders Place Their Bets

In related news, VP Fredrik Widman sold 2,067 shares of the firm’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the completion of the sale, the vice president directly owned 473 shares of the company’s stock, valued at approximately $260,150. This trade represents a 81.38% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Craig H. Barratt sold 2,193 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $548.01, for a total value of $1,201,785.93. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 98,078 shares of company stock worth $51,445,892. 0.70% of the stock is currently owned by company insiders.

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.